Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aegeria Soft Tissue

2009 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
1 INVESTORS
Description

Developer of tissue reconstruction technologies. The company develops tissue reconstruction technologies that provides a natural structure to mimic normal soft tissue and promote new fat tissue growth.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 7 Street, Paul Street
  • Suite 1660
  • Baltimore, MD 21202
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aegeria Soft Tissue’s full profile, request a free trial.

Aegeria Soft Tissue Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Oct-2011 Completed Startup
1. Accelerator/Incubator 01-Jan-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Aegeria Soft Tissue Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0

Aegeria Soft Tissue Executive Team (4)

Name Title Board
Seat
Contact
Info
Alessandro Ovi Co-Founder
Jennifer Elisseeff Ph.D Co-Founder
Lee Marks Co-Founder
Patrick Byrne MD Chief Medical Officer